Rare presentation of neurometabolic disorder (Wilson’s disease)

A case report and review of literature

https://doi.org/10.53730/ijhs.v6nS6.12820

Authors

  • Dinesh Kumar Assistant professor, Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab, India
  • Gursimran Kaur Student, Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab, India
  • Ashima Gupta Intern, Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab, India

Keywords:

Wilson’s disease, copper accumulation, liver cirrhosis

Abstract

Introduction: Wilson's disease (WD) is a disorder of copper metabolism leading to the accumulation of this metal in different organs. Hepatic manifestations tend to occur in the first decade and neurological symptoms in the third decade. Neurological manifestations are said to worsen with chelation therapy. Case report: A 16-year-old male presented to our institution with recurrent episodes of seizures since last 3 months despite being on multiple anti-epileptic medications. Patient eventually progressed to having problems while moving all his four limbs which further progressed to speech arrest and extraocular muscle palsy. MRI scan confirmed typical features of Neurometabolic disorder. Metabolic parameters like Ceruloplasmin level were also evidently low. Conclusion: Wilson’s disease is an inherited metabolic disorder. Early diagnosis and appropriate management help to prevent the systemic complications. Siblings needed to be screened to prevent manifestations. It also points out the need to suspect Wilson’s disease in any young patient presented with the unexplained liver disease.

Downloads

Download data is not yet available.

References

Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 2005;41:668-670.

Beinhardt S, Leiss W, St€attermayer AF, Graziadei I, Zoller H, Stauber R, et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol 2014;12:683-689.

Ferenci P, Czlonkowska A, Stremmel W, Houwen R, Rosenberg W, Schilsky M. European Association for Study of Liver. EASL clinical practice guidelines: Wilson’s disease. J Hepatol 2012;56:671-685.

Hitoshi S, Iwata M, Yoshikawa K. Midbrain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry. 1991;54:624–6.

Jacobs DA, Markowitz CE, Liebeskind DS, Galetta SL. The double panda sign in Wilson's disease. Neurology. 2003;61:969.

Kim TJ, Kim IO, Kim WS, Cheon JE, Moon SG, Kwon JW, et al. MR imaging of the brain in Wilson disease of childhood: Findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol. 2006;27:1373–8.

Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089.

Rosencrantz R, Schilsky M. Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis 2011;31:245-259.

Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011;140:1189-1198.

Published

18-09-2022

How to Cite

Kumar, D., Kaur, G., & Gupta, A. (2022). Rare presentation of neurometabolic disorder (Wilson’s disease): A case report and review of literature. International Journal of Health Sciences, 6(S6), 10545–10549. https://doi.org/10.53730/ijhs.v6nS6.12820

Issue

Section

Peer Review Articles

Most read articles by the same author(s)